Molecular response to aromatase inhibitor treatment in primary breast cancer
-
* Corresponding author: Alan Mackay alan.mackay@icr.ac.uk
- Equal contributors
1 The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, Fulham Road, London, SW3 6JB, UK
2 Academic Department of Biochemistry, Royal Marsden Hospital, Fulham Road, London, SW3 6JJ, UK
3 The Edinburgh Breast Unit, Western General Hospital, Edinburgh, EH4 2XU, UK
4 Novartis Pharma AG, Basel, Switzerland
Breast Cancer Research 2007, 9:R37 doi:10.1186/bcr1732
Published: 7 June 2007Additional files
Additional file 6:
Annotation of the Breakthrough 17K microarray
Format: XLS Size: 2.8MB Download file
This file can be viewed with: Microsoft Excel Viewer
Additional file 1:
Primer sequences used in RT-PCR
Format: XLS Size: 12KB Download file
This file can be viewed with: Microsoft Excel Viewer
Additional file 2:
A summary of relevant patient information
Format: XLS Size: 40KB Download file
This file can be viewed with: Microsoft Excel Viewer
Additional file 10:
Complete annotation of the genes in the 2418 heatmap
Format: XLS Size: 448KB Download file
This file can be viewed with: Microsoft Excel Viewer
Additional file 3:
A table of individual results used to plot GIDE correlations in figure 2
Format: XLS Size: 15KB Download file
This file can be viewed with: Microsoft Excel Viewer
Additional file 4:
An excel sheet listing all genes significantly up- and downregulated by AI treatment
Format: XLS Size: 1.9MB Download file
This file can be viewed with: Microsoft Excel Viewer
Additional file 14:
Complete annotation of the genes in the 421 heatmap
Format: XLS Size: 96KB Download file
This file can be viewed with: Microsoft Excel Viewer
Additional file 5:
An excel sheet listing all genes positively and negatively correlated with ESR1 expression
Format: XLS Size: 133KB Download file
This file can be viewed with: Microsoft Excel Viewer
